{"Abstract": [0], "The": [1, 94, 155, 268], "Central": [2], "Brain": [3], "Tumor": [4], "Registry": [5], "of": [6, 75, 101, 152, 168, 173, 187, 192, 219, 255, 263, 275], "the": [7, 14, 22, 27, 44, 50, 57, 84, 178, 216, 293], "United": [8, 45], "States": [9, 46], "(CBTRUS),": [10], "in": [11, 43, 73, 126, 200, 207], "collaboration": [12], "with": [13], "Centers": [15], "for": [16, 150, 285], "Disease": [17], "Control": [18], "and": [19, 21, 36, 48, 67, 77, 89, 104, 107, 118, 136, 161, 171, 177, 190, 202, 211, 223, 240, 246, 260, 279, 289], "Prevention": [20], "National": [23], "Cancer": [24], "Institute,": [25], "is": [26], "largest": [28], "population-based": [29, 60], "registry": [30], "focused": [31], "exclusively": [32], "on": [33, 62], "primary": [34, 63, 221], "brain": [35, 64, 106, 160, 222, 239, 278, 288], "other": [37, 108, 162, 224, 241, 280, 290], "central": [38], "nervous": [39], "system": [40], "(CNS)": [41], "tumors": [42, 65, 110, 170, 189, 226, 243], "(US)": [47], "represents": [49, 249], "entire": [51], "US": [52, 86], "population.": [53, 93, 231], "This": [54, 121, 248], "report": [55], "contains": [56], "most": [58, 156, 179], "up-to-date": [59], "data": [61], "available": [66], "supersedes": [68], "all": [69, 102, 153, 169, 174, 188, 193, 220], "previous": [70], "CBTRUS": [71], "reports": [72], "terms": [74], "completeness": [76], "accuracy.": [78], "All": [79], "rates": [80], "are": [81], "age-adjusted": [82, 97], "using": [83], "2000": [85], "standard": [87], "population": [88, 115, 259], "presented": [90], "per": [91, 113, 134, 146, 229, 257, 266], "100,000": [92, 114, 230, 258], "average": [95, 251, 262], "annual": [96, 252], "incidence": [98, 217], "rate": [99, 123, 218, 254, 272, 297], "(AAAIR)": [100], "malignant": [103, 159, 175, 238, 277], "non-malignant": [105, 119, 182, 194, 287], "CNS": [109, 163, 225, 242, 281, 291], "was": [111, 124, 165, 184, 227, 283, 298], "24.83": [112], "(malignant": [116], "AAAIR=6.94": [117], "AAAIR=17.88).": [120], "overall": [122], "higher": [125], "females": [127], "compared": [128, 139], "to": [129, 140, 237], "males": [130], "(27.85": [131], "versus": [132, 144], "21.62": [133], "100,000)": [135], "non-Hispanic": [137], "persons": [138, 142], "Hispanic": [141], "(25.24": [143], "22.61": [145], "100,000).": [147], "Gliomas": [148], "accounted": [149], "26.3%": [151], "tumors.": [154], "commonly": [157], "occurring": [158], "histopathology": [164, 183], "glioblastoma": [166], "(14.2%": [167], "50.9%": [172], "tumors),": [176], "common": [180, 199, 206], "predominantly": [181], "meningioma": [185], "(40.8%": [186], "56.2%": [191], "tumors).": [195], "Glioblastomas": [196], "were": [197, 204, 233], "more": [198, 205], "males,": [201], "meningiomas": [203], "females.": [208], "In": [209], "children": [210], "adolescents": [212], "(ages": [213], "0-19": [214], "years),": [215], "6.13": [228], "There": [232], "86,030": [234], "deaths": [235, 265], "attributed": [236], "between": [244], "2016": [245], "2020.": [247], "an": [250, 261], "mortality": [253], "4.42": [256], "17,206": [264], "year.": [267], "five-year": [269, 294], "relative": [270, 295], "survival": [271, 296], "following": [273], "diagnosis": [274], "a": [276, 286], "tumor": [282, 292], "35.7%,": [284], "91.8%.": [299]}